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     If approved by the Food and Drug Administration (FDA), the genetically modified 
salmon will be the first genetically engineered animal available for human consumption 
in the United States. The country relies on the Food and Drug Administration and other 
federal and state agencies to develop policies that consider unbiased evidence and 
expert policy development in the evaluation of food products.   
     I propose that the current information available regarding the acceptance of 
genetically modified salmon as a human food is not yet adequate for approval, as 
evidenced by the number of related public health issues that still remain unresolved.   
     A thorough review of the literature with a focus on the United States was conducted 
and various perspectives were analyzed. Sources included books, websites, journal 
publications, news sources, government documents and publications, legal 
perspectives and information from biotechnology (biotech) companies.  
     Findings revealed that genetically modified food remains a controversial topic for 
public health, and includes environmental, health, and ethical issues. There is still much 
debate about the regulation and safety of these foods in general, and escalating 
concern with the possibility of the genetically engineered salmon being approved for 
entry into the food chain without data on the long term impacts on human health and the 
animal population.    
     Improved processes regarding the regulatory and safety review of genetically 
modified foods are necessary to safeguard the public and environment. The FDA is 
mandated to protect public safety, and FDA policies must put the safety of the public 
before the wishes of biotech companies, until the assurance of long term safety can be 
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improved. Therefore, improved regulation, including labeling of foods with genetically 
modified content, can protect consumers while allowing them to make informed 
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Preface 
     While working as a Registered Dietitian in Public Health, I became aware of a 
controversial trend regarding America’s food supply. Biotechnology was having an 
increasing presence in the foods Americans consumed every day, and consumers were 
unaware of the change taking place over the years. Genetically modified organisms (or 
GMO’s), had gradually become part of agricultural crops, but there was a new item 
awaiting approval at the time this paper was being written: the genetically modified 
salmon, the first genetically engineered animal that would become part of our food 
supply.  
     Viewed as a positive contribution by some, but as negative by others, I was intrigued 
as to how the story of this genetically modified (GM) salmon would unfold. Was the 
United States of America ready for this next step in science and history? Was it safe 
from a public health perspective? I wondered whose decision it would be to approve this 
new food for our consumption and how would conclusions be formed? Would I eat it, 
and will consumers have adequate information available to enable them to make 
informed choices? As a public health leader, I want to be prepared with accurate 
information for myself, and when asked questions about genetically modified foods by 
others. 
     This paper will summarize the current issues regarding the new salmon, and 
formulate hypothetical policy recommendations that would satisfy the regulatory 
agencies, and provide fair and supportive requirements for producers. Ultimately, the 
goal of the GM salmon policies will be to assure safety for consumption and provide 
increased peace of mind for consumers in the United States.  
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     I will be watching, along with the rest of the country, to see if the salmon may 
become a genetically modified main course offered for our dinner tables soon. If it is 
approved, we will have to decide if it is a good choice for ourselves, our families, and 
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Introduction  
     Genetic modification of crops and animals has a long and controversial history, but 
has increasingly touched on public health issues over the past several decades. 
Genetic engineering challenges moral, political, personal, ethical (Olesen, Myhr, & 
Rosendal, 2010), and even religious beliefs and values (Federici, n.d.), while pushing 
the limits of science and biotechnology. Some feel that GM of food is a solution to many 
of the world’s food and related public health issues (BBC News, 1999; Coghlan, 2010; 
Lomborg & Post, 2013) while certain countries have said a loud ‘no’ due to related 
concerns (Federici, n.d.). In the United States, however, the debate is still going strong, 
but has become more heated as regulatory agencies develop policies regarding 
controversial genetically modified (GM) animals with the potential to enter the food 
chain (Homer, 2011). Because the long term human health impacts of GM foods are not 
fully known, this is a serious decision that has the potential to affect everyone living in 
the United States. Genetic modification of the salmon has put the spotlight on the battle 
of government regulation versus free enterprise (Homer, 2011). This paper will explore 
the relevant issues, examine several perspectives, and suggest policy 
recommendations designed to improve protection of the public’s health in this country. 
 
Theoretical Perspective 
     People in the United States may be unaware of the process that underlies assuring 
the safety of our food supply and environment. Some may believe that the regulatory 
bodies have the most accurate information about safety and potential problems with 
new food products, and will protect us from all harm. Others may trust that genetically 
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modified foods may be better for us than their non-modified counterparts, and assume 
that there is not any health or environmental risks involved with the GM foods, 
specifically the salmon. I propose that the current regulatory system has not adequately 
addressed all the aspects of the pending GM salmon approval, as evidenced by the 
number of unresolved issues, for example, inadequate environmental assessment by 
the FDA, unresolved labeling controversies, lack of long term health data, and 
regulatory classification issues. Improvements to the regulation and labeling of the GM 
salmon should address the concerns of consumers and stakeholders (Mason, Leavitt, & 
Chaffee, 2007), define specific guidelines for safety, correct any shortcomings of current 
regulatory processes, and implement policies that will educate and protect consumers.  
 
Methods 
     A literature search revealed a great deal of information about the history, issues, 
controversies, stakeholders and policies surrounding GM foods, particularly the GM 
salmon in the United States. The search was completed in three phases to educate 
myself on the history of GM foods in general, including the scientific background of GM 
foods, biotech companies, consumer concerns, regulatory agencies, labeling issues and 
political controversies surrounding the topic. Key search terms used were ‘genetically 
modified foods basics’, ‘genetically modified foods and (basics or overview)’, ‘GMO 
foods labeling’, ‘GMO foods Monsanto’, ‘start of GMO foods’, ‘battle brewing over 
labeling of genetically modified food’, ‘should GMO foods be labeled US’ (parameters: 
since 2012), ‘GMO foods FDA’, and ‘GMO salmon’. Due to the quickly changing 
developments surrounding the topic, particularly the GM salmon, grey literature was 
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included in the search to obtain information regarding current developments, issues, 
and global news events about GM foods. 
 
Results 
     The first search utilized the following search engines: Articles +, Lexis Nexis 
Academic, Google Scholar, Google, and the UNC Health and Sciences Library Catalog, 
and revealed thirty seven sources (see Appendix A), and some notable information: 
 Many consumers are not likely aware they are already consuming GM foods. By 
2011, 88% of corn and 94% of soybeans were genetically modified, while 70-
75% of processed foods contained genetically modified ingredients (United 
States Department of Agriculture [USDA], 2011).  
 There is documented concern that a prominent member of the Food and Drug 
Administration (FDA), Michael Taylor, the Deputy Commissioner of Foods, was 
previously employed by Monsanto, and may be influential in FDA decisions, and 
putting the demands of the biotech giant before the safety of the public (Flock, 
2012; Robin, 2010). 
 As documented by Dahl (2012), six European countries have banned the 
cultivation and import of GM foods, and fifty nations have labeling requirements 
for GE food products (Dahl, 2012) 
      Several books were reviewed that dealt with controversial issues such as labeling 
requirements (Marchant, Cardineau, & Redick, 2010) and the history of GM foods and 
biotech companies, mainly Monsanto, which was formerly a chemical company (Robin, 
2010). The issues discussed in these sources included: 
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 Biotech companies developed and have been responsible for dioxin (a 
component in the herbicide more commonly referred to as Agent Orange) that is 
associated with identified diseases and birth defects (United States Department 
of Veterans Affairs, 2013), as well as the now banned insecticides DDT/PCB’s 
(Environmental Protection Agency [EPA], 2012; Environmental Protection 
Agency [EPA], 2013).  
  NutraSweet® (aspartame), Roundup®, and Posilac® bovine growth hormones 
(rBGH), which are not banned, but have had controversial pasts due to various 
concerns regarding human and animal health issues, have also been produced 
by biotech companies (Robin, 2010).  
 Monsanto owns 90% of the patents for GM crops, including the patents for the 
herbicide Roundup® and Roundup Ready® seeds, which can be planted and 
will germinate almost immediately after the Roundup® herbicide application; 
these GM seeds cannot be saved by farmers who may typically save part of a 
harvest for seeds (Robin, 2010). Monsanto’s GM crops have been blamed for 
the collapse of pollinating bees (The Star [Nairobi], 2013).  
 Robin (2010) highlights the concerns of this biotech giant’s past products, some 
of which were originally approved as safe, but later were deemed harmful after 
the company made huge economic gains. This negative history has raised 
concerns that GM crops, as well as the GM salmon may not be safe enough for 
human consumption. 
     It was a challenging search and difficult to find information that had limited bias, due 
to the tendency of many sources to be polarized on certain issues. Specifically 
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regarding the GM salmon, if approved, it will be the first genetically modified animal 
approved for human consumption in the United States (Pollack, 2010).  
     One extremely valuable resource was a well-referenced 54 page journal article from 
the peer reviewed Columbia Journal of Law and Social Problems (Homer, 2011), titled 
“Frankenfish…It’s What’s for Dinner: The FDA, Genetically Engineered Salmon, and the 
Flawed Regulation of Biotechnology”, which cited many sources, some of which led to 
additional resources for this paper. Another informative resource was an academic 
paper titled “The Debate on Labeling Genetically Modified Foods” by a team of students 
from the University of Iowa; however, sections were poorly cited, making it difficult to 
determine the original sources of information (Damery, D’Adamo, Graham, Hoffman, & 
Riedl, 2011). 
     A second round of searches (See Appendix B) focused on government websites to 
locate documents, bills, and information regarding regulatory agencies and processes, 
history, national laws, state laws and upcoming issues of debate. Search terms included 
‘CDC genetically modified foods’, ‘FDA GM salmon’, and various related searches for 
timelines and supporting documents. The FDA website 
http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering
/GeneticallyEngineeredAnimals/default.htm  (Food and Drug Administration [FDA], 
2012a) provided the most timely information on the status of the GM salmon and public 
information on GM foods. In addition, it was necessary to research information about 
current regulation of food products and the approval process. The most significant 
document was GFI #187 Regulation of Genetically Engineered Animals Containing 
Heritable Recombinant DNA Constructs (Food and Drug Administration [FDA], 2009b). 
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     As the search deepened, the topic evolved from GM food labeling issues to public 
safety after it was discovered that new GM food labeling laws were becoming effective 
in Connecticut on October 1, 2013, with bills in other states in the works. It should be 
noted that food labeling does not guarantee public safety, but provides one measure 
that empowers the public to make informed choices for themselves and their families. 
Based on these findings, the search focus then became the safety assurance of 
genetically modified salmon. Additional sources were pulled from the original articles 
identified by the initial literature search findings listed in Appendix A. The review of 
these additional sources revealed that there are many public health issues under 
debate regarding GM foods, including environmental, health, and regulatory 




     Genetic manipulation of organisms is not a new technology. At first, it was nurtured 
to develop crops with improved yield or resistance to negative environmental effects 
(Halford & Shewry, 2000). Plants were first studied and then efforts evolved to animals 
in the 1980’s (gmeducation.org, n.d.), and the topic of genetically modified organisms 
became more controversial as it challenged cultural values, the regulatory framework 
and political issues such as international trade (Vàzquez-Salat, Salter, Smets, & 
Houdebine, 2012). Appendix D provides a comprehensive list of significant dates in the 
history of genetically modified foods. Today, food biotech companies remain at the 
center of the controversy, plagued by accusations of putting the safety of the consumer 
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behind monetary gain, monopolizing the seed industry, and unfair practices toward 
farmers (Flock, 2012; Oloya, 2010; Robin, 2010).                     
     In the United States, GM crops and vegetables have been gradually introduced to 
consumers, but the GM salmon is raising more concern due to uncertainties with its 
safety (Homer, 2011), that relates to issues about the regulatory processes for 
genetically modified food approval and monitoring in the United States, and encourages 
scrutiny of the current policies.    
      What exactly is genetically modified salmon? The experts have noted that 
genetically engineered salmon is created by adding genes from the Chinook salmon 
and the Ocean Pout to the Atlantic salmon. This modification allows the salmon to 
produce growth hormone all year round, instead of the natural partial year, and speeds 
up growth to market size of 3-4 kilograms in 18 months instead of 24-30 months as 
shown in Figure 1 (AquaBounty Technologies, 2013b; Office of Science & Technology 
Policy, 2001).  
 
Figure1. Growth Comparison of AquAdvantage Salmon to Standard Salmon (AquaBounty Technologies, 
2013b)   
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Potential benefits of GM salmon: 
     Genetically modified salmon have positive potential, and could even help meet an 
increased demand for salmon and protect wild fish stocks (some salmon populations 
are endangered now) (Veterinary Medicine Advisory Committee, 2010). They require 
less feed and can be sold more quickly (AquaBounty Technologies, 2013a). 
In addition, GM salmon farming can lessen the carbon footprint of overfishing and 
production (AquaBounty Technologies, 2013c), and has the potential for increased 
investments in the product, helping the US economy (AquaBounty Technologies, 
2013c). Aquaculture in the United States currently generates approximately one billion 
dollars annually (Goldburg, Elliot, & Naylor, 2001). The GM fish provide increased 
economic efficiency and profits for commodity fish producers (Clausen & Longo, 2012) 
and may help meet food demand globally (BBC News, 1999; Homer, 2011). According 
to Menozzi et al. (2012), if the GM salmon is accepted by consumers it may be less 
expensive, thus resulting in increased intake. Finally, an increase in Omega 3 fatty 
acids may improve health, especially those of lower socioeconomic status, in turn 
improving public health (McLaren, 2007; Smith, Asche, Guttormsen, & Wiener, 2010) 
 
Regulation, Current Policies and Evolution of the Current Regulatory Process 
     Before analyzing the current regulatory agencies and their policies, it is important to 
understand how the policies were developed, and lead to the resulting challenges we 
face today with the GM salmon. During the 1980’s, regulatory agencies had overlapping 
responsibilities, which led to confusion when biotechnology emerged. The Domestic 
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Council Policy Working Group was formed, along with the White House Office of 
Science and Technology Policy (OSTP) (PewTrusts.org, 2001). The Coordinated 
Framework for Regulation of Biotechnology was developed (Office of Science & 
Technology Policy, 1986; PewTrusts.org, 2001); Homer (2011) highlights the fact that 
the framework has changed little since 1980’s, and decisions reached by this entity are 
not legally binding. The Coordinated Framework had agencies base decisions and 
regulations on outdated laws created prior to advances in biotechnology. In fact, the 
Coordinated Framework concluded that “(GM) products are not inherently riskier than 
their natural analogs, and, therefore, that (GM) products can be adequately regulated by 
the pre-existing statutory and regulatory structure”, which are the same regulations as 
for the conventionally produced counterparts (Office of Science & Technology Policy, 
1986). 
     No single agency became solely responsible for both the evaluation of safety and 
regulation of the production of GE foods based on interpretation of previous laws 
(PewTrusts.org, 2001). The FDA is supposed to oversee food safety of all GE food 
products for human consumption (National Research Council, 2002) based on the 
Federal Food, Drug and Cosmetic Act (FDCA) of 1938 (United States House of 
Representatives, 1938). Further, Section 402 of the FDCA authorizes regulation of 
adulterated foods (poisonous or deleterious substances), and Section 409 of the FDCA 
regulates food additives, but manufacturers do not need FDA approval if an additive is 
Generally Recognized As Safe (GRAS) (United States House of Representatives, 
1938). In 1992, the FDA issued the “Statement of Policy: Foods Derived from New Plant 
Varieties” (Food and Drug Administration [FDA], 1997). The FDA presumed GE crops 
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were safe based on the fact that nucleic acids added to these crops were GRAS, and 
left it up to manufacturer to be responsible for product safety, making most GE foods 
exempt from safety reviews. In 1996 and again in 2006, the FDA published guidance for 
producers to voluntarily consult with them before marketing GM foods. The FDA 
consultation was to evaluate the developers’ conclusions and only considers human 
risk, not environmental or ecological (Food and Drug Administration [FDA], 1997).   
     As GE animals were being developed, in 2009, the FDA issued “Guidance for 
Industry 187: Regulation of Genetically Engineered Animals Containing Heritable 
Constructs” (Food and Drug Administration [FDA], 2009b) and claimed regulatory 
authority over GE animals under FDCA’s “new animal drug” authority (as the FDA also 
regulates pharmaceuticals for humans and animals per the FDCA) (United States 
House of Representatives, 1938). 
     To initiate the process, the developer files a New Animal Drug Application (NADA), 
for a drug to be used in any animal other than a human, including drugs in animal feed 
(United States House of Representatives, 1938)  see Figure 2. The definition of a drug 
is any article other than food intended to affect the structure or function of the body 
(both animals and human) (United States House of Representatives, 1938). 
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      An Engineered Recombinant DNA (rDNA) construct is a non-food article, intended 
to affect the structure or function of a GE animal, and considered a veterinary drug by 
definition, and focuses only on health issues, not environmental (Mandel, 2004). 
FDCA’s definition of a “new animal drug” specifies the drugs are not ‘GRAS’, conflicting 
with the food aspect of GM foods being GRAS (rDNA added to crops is GRAS while 
rDNA added to animals is not GRAS because of the NAD status (United States House 
of Representatives, 1938). GE animal food products are under veterinary drugs, and 
reviewed by the Center for Veterinary Medicine (CVM) rather than Center for Food 
Safety and Applied Nutrition (CFSAN) (Food and Drug Administration [FDA], 2009) the 
consequence of GM foods being classified as a new veterinary drug (Mandel, 2004). 
     Due to the Trade Secrets Act, the FDA could not reveal information acquired through 
the NADA process (Americans usually do not know much about a product until its 
release) (Office of Science & Technology Policy, 2001; Pollack, 2010), putting limits on 
transparency. In 1995, AquaBounty, the company that intends to supply GE salmon 
eggs to fish farms (Food & Water Europe, 2010), submitted information on ten 
generations of their GE AquaAdvantage salmon, and the CVM (Center for Veterinary 
Medicine) held the Veterinary Medicine Advisory Committee (VMAC) meeting to release 
preliminary public information, and obtain outside expert advice. (Naik, 2010).  
      The FDA’s position was that the 2007 Food and Drug Administration Amendments 
Act (FDAAA), the Endangered Species Act (ESA), and the National Environmental 
Protection Act (NEPA) gave them authority to regulate environmental aspects of the GM 
salmon (Office of Science & Technology Policy, 2001), and this was reinforced by 
information submitted by Aquabounty assuring containment of the GM salmon (Homer, 
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2011). This position was undertaken to fill the gaps of the other agencies since the 
Environmental Protection Agency (EPA) interprets its regulation over the environmental 
risks, but no regulatory authority over GE animals (Mandel, 2004), and the USDA 
Animal and Plant Health Inspection Service (APHIS) only monitors the health of GM 
livestock, completes inspections before and after slaughter, and monitors GM veterinary 
medicine products (Vàzquez-Salat, Salter, Smets, & Houdebine, 2012). In the case of 
the GM salmon, the FDA has issued a Findings of No Significant Impact (FONSI) status 
but no complete Environmental Impact Statement (EIS) (Food and Drug Administration 
[FDA], 2010). To some, this appears as ‘foot dragging’ approval of GM salmon (Noah, 
2013). As a result, there is no federal agency effectively handling the environmental 
impact aspect to the safety of these GM consumer foods (Homer, 2011). 
     An additional concern about GE regulation is that in 2013, HR 933 section 735 was 
passed, which protects biotech companies by allowing them to continue selling GM 
seeds while legal action may be in process against them, and continue sales even if the 
crops are deemed harmful to humans (United States Congress, 2013). This resolution 
was controversial because it was ‘slipped in’ with a larger bill, according to some 
(Gibson, 2013), and puts the interest of biotech companies ahead of the assurance of 
safety by the regulatory authorities. The bottom line is not only are the regulations 
based on limited data, but because of the different regulatory jurisdictions, there remain 
gaps in assessing and evaluating the full impact of GM salmon on humans and the 
environment. 
     The FDA has divided genetically modified animals into six categories: 
1) Produce pharmaceuticals to be used for other animals and humans 
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2) Decrease the environmental impact of large-scale agricultural practices by 
decreasing the amount of chemicals such as phosphate in manure, thereby reducing 
water pollution 
3) Serve as a source of cells, tissue, and organs closely matched to humans so that 
they may be able to be transplanted into humans without rejection 
4) Produce high value materials such as those used for surgical sutures and personal 
protection devices such as body armor for military and law enforcement use 
5) Produce highly specific antimicrobials that cause disease-causing bacteria such as 
E. coli 0157:H7 or Salmonella 
6) Provide more healthful or more efficiently produced food (Food and Drug 
Administration [FDA], 2012b).  
 
     If approved, the GM salmon would be the first GE fish approved for human 
consumption in the United States (Bratspies, 2005; Erickson, 2009; Homer, 2011; 
Pollack, 2010; Voosen, 2010). 
 
Current Controversies 
Health Concerns: Short and Long Term- Too Early for Approval? 
     According to the US Genome Program, the human health impacts from GM food 
products are not fully known, as stated earlier (US Department of Energy Genome 
Program, 2012). There are concerns about the risk of exacerbated allergies in humans 
who consume GM products (Goodman & Tetteh, 2011; US Department of Energy 
Genome Program, 2012; Winter, C. K., Gallegos, L. K., 2006), and also that negative 
animal feeding studies showing toxicity and resulting organ problems may not have 
been reported or not reported accurately (Robin, 2010).  
     Due to problems with other GM food sources, previous GM crops have been 
removed from production (Starlink® corn) or not allowed to enter production (GM 
potato), (Winter, C. K., Gallegos, L. K., 2006), it is possible that GM animals may be 
similar. Allowing a GM animal into the food chain is perceived as risky at this time, 
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considering there are still unknown effects (Farquhar & Meyer, 2007; US Department of 
Energy Genome Program, 2012). 
     An article by Seralini et al. (2011) suggests that results of some tests on the health 
effects of GM crops on animals have not been adequately interpreted and disclosed. 
The article concluded that additional, longer, and more thorough testing is ethically 
necessary, along with post-market monitoring for human populations already exposed 
(Séralini et al., 2011). According to Menozzi et al, experts “speculated that consumer 
health is more likely to be harmed than improved by GM salmon” (Menozzi, Mora, & 
Merigo, 2012).   
     As documented by Spiroux De Vendomois et al., additional studies have 
demonstrated that the GM salmon is not as nutritious as its traditional counterpart (ge-
fish.org, n.d.), and it may lead to complications with substance toxicities, and further 
antibiotic resistance, especially if the salmon ingest GM feed products (Spiroux De 
Vendômois, Roullier, Cellier, & Séralini, 2009). 
Have environmental concerns been adequately evaluated? 
     There are also potential negative risks with the GM salmon to be considered. Escape 
risk from facilities, leading to potential mating with wild populations, could damage or 
even cause extinction of wild salmon populations and other wildlife (Howard, DeWoody, 
& Muir, 2004). Sterilization (triploidy) has been shown to be effective in only 95% of 
AquaBounty’s GM salmon eggs (Food and Drug Administration [FDA], 2010) Although 
difficult to estimate, researchers have concluded that other invasive species (for 
example, Asian carp) have caused environmental damages up to an estimated $120 
billion per year, including interference with the fishing industry, clogging dam systems, 
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attacking other species of aquatic life, and the resulting expenses from controlling such 
invasions (Eilperin, 2010). Devlin et al. expose the concerns regarding the potential of 
problems with escaped GM salmon could have other devastating environmental effects 
(Devlin, D'Andrade, Uh, & Biagi, 2004). 
     The same study by Devlin et al. revealed some GE salmon are more aggressive and 
sometimes resort to cannibalism during periods of low food supply (Devlin et al., 2004). 
These situations could cause unpredictable impacts on an ecosystem (Farquhar & 
Meyer, 2007; National Research Council, 2002). Farmed GM salmon may require large 
amounts of antibiotics (Naik, 2010), which could lead to antibiotic resistance (US 
Department of Energy Genome Program, 2012). Others have indicated that GM salmon 
farming will reduce preservation and restoration of wild fisheries (Clausen & Longo, 
2012). There are environmental safety concerns based on the history of previous tragic 
biotech company chemical incidents such as Agent Orange, DDT and PCB’s 
(Environmental Protection Agency [EPA], 2012; Environmental Protection Agency 
[EPA], 2013; Robin, 2010; United States Department of Veterans Affairs, 2013) which 
have led to questions about adequacy of safety assessments and practices by biotech 
companies. Since the GM Salmon farms are to be located in other countries such as 
Panama (The Development Fund, 2013), it is likely that these farms cannot be 
monitored closely by the FDA and USDA.  
Inappropriate Classification for Regulatory Review 
     The current regulatory process for GM foods was devised while only agricultural 
products were being developed and GM animals were under consideration for uses that 
did not include human food consumption, as discussed under the Evolution of the 
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Current Regulatory Process section (also refer to Appendix D). From my determination, 
the FDA has not adequately consulted with other federal agencies concerning the GM 
salmon, since they have completed a FONSI, but not an EIS for AquAdvantage Salmon 
(Food and Drug Administration [FDA], 2010). Therefore, the FDA has not completed a 
full environmental assessment, and is not the appropriate agency to do this based on 
the FDAAA. Likewise, critics feel that the VMAC and CVM are not the appropriate 
agency to evaluate this salmon in terms of food safety (Homer, 2011). Since the 
approval of the GM salmon could establish the regulatory review precedence and open 
the door for other GE food animals for human consumption (Homer, 2011), adequate 
completion of each of these assessments and complete evaluation of these data are 
vital before the GM salmon possibly becomes a large part of our food supply.   
Unresolved Consumer Choice Issues: Labeling of the GM Salmon 
     Some stores have announced they will reject GM seafood (Friends of the Earth, 
n.d.), and it has been postulated that other countries will likely reject imports of the GM 
salmon (Dahl, 2012). These decisions appear to be based on the knowledge that many 
still prefer knowing salmon is wild caught as opposed to farmed salmon (Clausen & 
Longo, 2012).   
     There continues to be controversy over whether or not GM foods should be labeled 
in the United States (Marchant, Cardineau, & Redick, 2010). Groups who support 
labeling include concerned US consumers (Marchant et al., 2010), those who wish to 
avoid GM salmon for religious reasons, special interest groups, producers of non-GMO 
foods, stores that refuse to carry some GM products (Friends of the Earth, n.d.), 
supporters of California Proposition 37 and the California Right to Know Genetically 
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Engineered Food Act (Dahl, 2012), as well as individual states such as Connecticut 
(State of Connecticut, 2013). The consumer’s right to know is the basis for this position. 
     There are also groups against labeling of GM foods, including GMO food 
manufacturers (Federici, n.d.), biotech companies (Dahl, 2012; Robin, 2010), 
agribusiness (Dahl, 2012), and some grocery stores (Dahl, 2012). Their position is 
based on the concern that labeling GM foods will cause a decrease in sales and is due 
to unwarranted concern about the safety of the food products (Marchant et al., 2010). 
 
Discussion  
     Potential approval of the GM salmon still remains a controversial subject in regards 
to public health issues such as assurance of human safety, environmental concerns, 
consumer acceptance and regulation. The GM salmon offers potential benefits, but it is 
still undecided if they are outweighed by the potential costs and risks, both known and 
unknown.  
     After a difficult battle, Connecticut was the first US state that passed laws that will 
require most GM foods to be labeled, as documented in substitute House Bill 6527 (sHB 
6527) (State of Connecticut, 2013). The bill includes the labeling of applicable seeds 
and seed stock, as well as infant formula and baby food. It does not apply to “(1) 
alcohol, (2) food not packaged for retail sale that is intended for immediate 
consumption, and (3) certain farm products”. In addition, the bill excludes any GM food 
to be marketed as “natural”, non-GM animals that were fed GM products, some foods 
processed with GM processing aids or enzymes, and foods that contain less than 0.9% 
total weight GM materials before July 1, 2019. The law subjects knowing violators of this 
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mandate to label the identified GM foods to a daily fine of up to $1,000 per day, and 
violators can face criminal charges. The Connecticut State Department of Consumer 
Protection (DCP) will be permitted to seize food or place embargos on foods (State of 
Connecticut, 2013). The amendment adds a defense for retailers who have relied on the 
disclosure of wholesalers. Several other states are working on the development of 
labeling laws for GM food products, but there are pros and cons of the labeling concept.   
PROS of Labeling GM Foods: 
     Appropriately labeling GM foods will result in better informed consumers, allowing 
them to make better choices, according to the opinion of Marchant et al., (2010). It may 
ease lack of confidence in the regulatory system since the emergence of the bovine 
spongiform encephalopathy (BSE) (BBC News, 1999), because it increases 
transparency (Zhang, 2013) GM foods may contain potential allergens (US Department 
of Energy Genome Program, 2012), therefore labeling could help decrease exposure 
and, afford ease of shopping to avoid risky products for some individuals (Zhang, 2013). 
Accurate labeling could also improve international trade relations so other countries can 
more easily identify GM versus non-GM products to comply with individual countries’ 
differing labeling regulations (Teisl & Caswell, 2003). 
CONS of Labeling GM Foods: 
     Some feel labeling will cause unwarranted concern over products that are actually 
safe (Marchant et al., 2010), resulting in avoidance of GM foods (Zhang, 2013). 
Additional labeling requirements would increase expenses for food producers (Dahl, 
2012; Marchant et al., 2010; Zhang, 2013), resulting in increased food prices (Marchant 
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et al., 2010). In addition, failure to comply with FDA labeling regulations can result in 
legal action and delayed production (Food and Drug Administration [FDA], 2009a).  
     The book Thwarting Consumer Choice, The Case Against Mandatory Labeling of 
Genetically Modified Foods by Marchant, Cardineau and Redick (2010), suggests the 
best option would be voluntary labeling of GM foods. This option still does not address 
the fact that some consumers are not as informed about the GM salmon, especially, 
and may be at risk for issues that may not yet have been identified. 
     On the other hand, a managed program (discussed later under Recommendations) 
could provide increased consumer education along with labeling standards, while still 
supporting the progress of GM foods (Federici, n.d.; Teisl & Caswell, 2003). This 
approach could also calm the battle between biotech companies, regulatory agencies, 
and the public in the United States.  
 
Recommendations 
     Consumer protection can be assured by strengthening public health policies. 
Regulatory agencies must put the health and well-being of consumers before the 
wishes of food biotech companies. This may cause further delay in the approval of the 
GM salmon, but it is imperative that assurance be provided before the approval process 
is completed. I recommend improved regulatory coordination and policies, further safety 
and environmental testing, and consistent labeling requirements for GM products prior 
to the approval of the GM salmon. 
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Assurance of Human Safety 
      The FDA should be responsible for evaluating the food safety aspects of the GM 
salmon, and not leave this aspect to interpretation based on the manufacturers’ 
conclusions alone. In addition, it should be evaluated as a non-GRAS human food 
product, not only as an animal veterinary drug. Partnering with the EPA to be 
responsible for environmental evaluations, combining expertise, and improving 
coordination between agencies will be essential to direct the required assessments. 
Further, the FDA should mandate research and evaluation from outside evaluating 
agencies and the manufacturers (such as by clinical research organizations), whereby 
these data are submitted directly to the FDA, bypassing manufacturers who could omit 
or change unfavorable data. This will also divert development and evaluation costs of 
GM foods to the biotech companies who will ultimately profit instead of government/tax 
payer funded evaluation. Evidence based research should be used to inform 
policymakers (Brownson, 2009), while controlled animal studies, all the way through to 
voluntary approved human studies should be required. The approval of the GM salmon 
for human consumption should be delayed until studies with a longer duration have 
been conducted and the results independently analyzed and reported. Lengthier, multi-
generational animal testing, combined with improved statistical analysis methods will 
help more appropriately analyze results of GM feeding trials (Séralini et al., 2011), in 
animals, then humans, and should be required by the FDA before the release of the GM 
salmon for widespread human consumption. If the GM salmon is approved, long term 
human health monitoring should take place among consumers using risk-based 
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monitoring to more effectively identify abnormal trends or issues (Food and Drug 
Administration [FDA], 2013). 
Protecting the Environment 
      The FDA should combine efforts with the EPA to complete the more thorough full 
environmental assessment (EIS or Environmental Impact Statement) before providing 
their recommendation for the approval of the GM salmon. It would be beneficial for the 
USDA to continue to support research regarding the inability of the female GM salmon 
to reproduce (reaching a reproducibility level of 0% as compared to the current 5%), to 
build upon an earlier USDA research grant to AquaBounty for this purpose (United 
States Department of Agriculture [USDA], 2011). Requirement of special permit 
licensing of GM salmon producers and distributors would help ensure compliance with 
standards, and help defer costs of the program to help ensure environmental safety. In 
addition, develop and institute specially licensed individuals to provide mandatory 
training for GM salmon farmers (similar to food service certification trainings). Pilot 
programs should only be allowed inside the borders of the United States at this time so 
fisheries can be monitored and regulated, with the possibility of expansion outside of the 
United States later. Finally, only inland fisheries should be permitted to prevent escape 
to bodies of water. 
Alleviating consumer concerns 
     Increased transparency (Homer, 2011) will be necessary to help the consumer gain 
trust in the US regulatory system for genetically modified foods for human consumption. 
The conversation should be revisited for public input before approval of GM salmon 
(public input should also include comments/concerns from experts, input to legal and 
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academic areas on the FDA website and through focus groups at universities and at 
events such as law meetings). Consumer knowledge and education should be 
expanded to increase awareness of GM foods, and made available through local health 
education programs, social media, schools and food assistance programs.  
     Labeling standards for GM foods will allow consumers to make the best choices for 
themselves and their families. Ideally these standards should be national, instead of 
state by state, to avoid potential commerce issues if products are shipped to states with 
different labeling requirements. Strict labeling standards to identify GM foods should be 
required until additional long term studies to assess the impact of GM salmon and other 
foods on the environment and humans. Evaluation of GM food labeling standards 
should be undertaken after long term data are available. 
     A suggested alternative per the book Thwarting Consumer Choice (Marchant et al., 
2010) is voluntary labeling, but this approach would still expose unaware consumers to 
possible harm. Basic, user friendly labeling, along with a consumer education program 
will educate unaware or fearful consumers while providing choices for individuals who 
wish to avoid GM salmon for health or other personal reasons. Combining efforts with 
the MyPlate.gov campaign, an already recognized website, could be a beneficial 
partnership. A pilot program focusing on consumer education about GM foods and 
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Conclusion 
     Gradually, those living in the US have been exposed to more genetically modified 
crops over the years, and they have been reasonably accepted (Homer, 2011). With the 
potential for a GM animal, in particular the salmon, entering the food chain, GM foods 
and the accompanying issues and policies have taken on a new spotlight. 
     It is imperative that these issues are examined from a public health standpoint, and 
gaps in the regulatory approval and oversight process need remediation before 
problems, including potential health, environmental and ethical problems may result. 
Once the GM salmon is approved for human consumption, it will not be as easy to turn 
back the clock. At this time, the risk may be at a higher cost than the benefits (Food & 
Water Europe, 2010), and it is my view this is true for the United States. It is essential 
for public health leaders to be actively involved in the regulatory review process and 
associated policymaking, to safeguard the best interest of the public, before the 
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Appendix D: Significant Dates in the History of Genetic Modification of Food 
 
1865- Gregor Mendel’s research on breeding of peas is published, which became the 
basis for modern genetics (gmeducation.org, n.d.) 
 
Prior to 1900- Seed saving from plants found in nature and crops, and natural hybrids 
among related plant varieties begin to be recognized by farmers and naturalists 
(American Radio Works, 2013) 
 
1931- Barbara McClintock and Harriet Creighton examine maize microscopically and 
show evidence of physical recombination (linking of DNA from different chromosomes) 
(gmeducation.org, n.d.) 
 
1973- Stanley Cohen and Herbert Boyer develop DNA cloning, allowing the transplant 
of genes between different biological species. The same year, the Ti plasm id in a 
bacteria is identified that can be used as a medium to genetically alter plants 
(gmeducation.org, n.d.) 
 
1974- The first genetically modified organism is created (gmeducation.org, n.d.), and 
the evolution of Recombinant DNA technology allows genetic engineers to create highly 
controllable and predictable breeding outcomes (Homer, 2011) 
 
1975- The United States holds a private conference with scientists to decide on self- 
regulation guidelines and the future path of genetic engineering (gmeducation.org, n.d.) 
 
1976- The NIH develops guidelines for GM research (gmeducation.org, n.d.) 
 
1980- US Supreme Court rules GM lifeforms can be patented in Diamond vs. 
Chakrabarty (American Radio Works, 2013; uspto.gov, ) 
 
1980- First genetically modified animal is created (mouse), and a domestic animal (pig) 
in 1985 (gmeducation.org, n.d.) 
 
1992- USDA approves Calgene’s Flvr Savr tomato for commercial production (American 
Radio Works, 2013) 
 
1992- FDA declares genetically modified foods do not need any additional regulations 
and are not inherently dangerous (American Radio Works, 2013) 
 
1994- Plant in vitro fertilization done on corn (gmeducation.org, n.d.) 
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1995- EPA approves use of the first pesticide producing crop (potato) and insect 
resistant corn in the US, and tobacco developed to produce hemoglobin (protein in 
human blood) (gmeducation.org, n.d.)  
 
1996- Monsanto’s Roundup Ready soybeans introduced in US, which will grow in 
glyphosate treated soil (gmeducation.org, n.d.)  
 
1998- First patent issued for genetically modified seeds with ‘Terminator Technology’, 
preventing saved seeds from reproducing (gmeducation.org, n.d.)  
 
2002- Biotech industries propose patent to protect ‘intellectual property’ 
(gmeducation.org) 
 
2009- The FDA publishes ‘Guidance for Industry: Regulation of Genetically Engineered 
Animals Containing Heritable Recombinant DNA Constructs (non-binding 
recommendations) (Food and Drug Administration [FDA], 2009b)      
 
By 2011, 88% of corn, 94% of soybeans% and 94% of cotton grown in the US was 
genetically engineered (Homer, 2011) 
 
2011- USDA grants Aquabounty Technologies nearly $500, 000 to research methods of 
rendering GM fish unable to reproduce (USDA, 2011) 
 
2013- FDA to decide if Genetically Engineered (GE) salmon approved for commercial 
cultivation and human consumption, while countless other GE animals are being 
developed (Homer, 2011) 
 
 
 
 
 
 
 
  
 
